Clinical Trials Logo

Filter by:
NCT ID: NCT03329872 Completed - Neurologic Disorder Clinical Trials

Neuro-Orthopedic Registry of the University Hospital of Toulouse

Start date: November 2014
Phase:
Study type: Observational [Patient Registry]

Neuro-orthopedics corresponds to the evaluation and therapeutic management of the orthopedic consequences of damage to the central or peripheral nervous system. In case of neurological impairment, there may be joint, motor, sensory and cognitive impairments that limit the patient's activities. The management of these orthopedic problems falls within the specific framework of neuro-orthopedics because in the presence of neurological, problems are different and more complex than in classical orthopedics. In this context, a well-conducted evaluation is a prerequisite for appropriate treatment.

NCT ID: NCT03329846 Completed - Melanoma Clinical Trials

An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma

Start date: November 30, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to see if BMS-986205 combined with nivolumab, compared to nivolumab by itself, is more effective in treating Melanoma that has spread or is unable to be removed by surgery, and has not previously been treated

NCT ID: NCT03329768 Completed - Clinical trials for Acute Infectious Diseases

Evaluation of Medical Device

Start date: September 28, 2016
Phase:
Study type: Observational

A preliminary study was conducted from 01/26/2015 to 10/26/2015 on 605 patients admitted to MIA with an intravenous and/or a urinary catheter. the investigators analyzed: - the demographic characteristics of the patient - the final diagnosis - the patient's severity and the patient outcome after discharge from MIA - the justification of the venous and or a urinary catheter - the duration of the prescription of the device Evaluation on admission of the need to maintain an intravenous or urinary catheter. Adjusting the prescription in terms of duration or withdrawal of the device in order to limit their complications (lymphangitis, superficial thrombophlebitis, bacteremia related to health care, urinary tract infection). Hypothesis: Limit the length of stay and reduce the cost of hospitalization.

NCT ID: NCT03329755 Completed - Melanoma Clinical Trials

Optimization of the Patient Care Pathway in Immuno-oncology

OPTIMMUNO
Start date: December 26, 2017
Phase: N/A
Study type: Interventional

This study compares the care pathway of melanoma patients treated by immunotherapy in two ambulatory care structures. The aim is to measure if a care structure specialized in immuno-oncology could rationalize the care of patients. This protocol will be based on two different follow-up during the treatment period: - dedicated and coordinated e-follow-up (IUCT-O in Toulouse) - standard follow-up (University Hospital Center in Bordeaux) Patients will be followed from the first cycle of immunotherapy until 3 months after the initiation treatment.

NCT ID: NCT03328949 Completed - Clinical trials for Coronary Artery Disease

Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)

Start date: May 18, 2018
Phase: N/A
Study type: Interventional

The objective of this post market study is to examine the safety and performance of the Shockwave Coronary Intravascular Lithotripsy System for the treatment of narrowed coronary arteries before the doctor places a stent.

NCT ID: NCT03328559 Completed - Bronchial Cancer Clinical Trials

Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer

Start date: March 7, 2016
Phase: N/A
Study type: Interventional

The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.

NCT ID: NCT03327493 Completed - Inflammation Clinical Trials

Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMO

ADRECMO
Start date: October 10, 2017
Phase: N/A
Study type: Interventional

Refractory cardiogenic shock is characterized by a decreased in cardiac output with hypo-responsiveness to increasing doses of catecholamines resulting in a profound tissular ischemia. VAECMO, by restoring a circulatory flow, could be associated to a major reperfusion syndrome which may lead some patients to multiple organ failures and death. Pathophysiology of this syndrome includes 1/an hyper-adrenergic state secondary to the over activation of the sympathetic system and 2/ a major release of pro-inflammatory cytokines. As adrenoreceptors are also exhibited on immunes cells, the pro-inflammatory state might be enhanced by the over-activation of the sympathetic system.

NCT ID: NCT03327415 Completed - Infants Clinical Trials

Nutri-Bébé 2013 Survey on Food Consumption of Infants and Young Children

NBB2013
Start date: January 3, 2013
Phase: N/A
Study type: Observational

The Nutri-Bébé 2013 survey is an observational cross-sectional study aiming to update food consumption, practices and nutrient intakes in children under 3 years of age in metropolitan France.

NCT ID: NCT03326908 Completed - Clinical trials for Tomography, Optical Coherence

Description of the Interdigitation Retinal Area by SD-OCT: An Exploratory Study

ODIGIT
Start date: October 12, 2017
Phase: N/A
Study type: Interventional

Improvement of retinal medical imaging opens new perspectives for exploring the retinal structures. Optical coherence spectral domain (SD-OCT), which has been widely used in the last ten years, is certainly the most advanced device. In the analysis of patients without retinal disease using SD-OCT, granulations in the interdigitation area were observed. These granulations have never been described with this device. They could correspond either to the degradation products of the external segments of the photoreceptors or to melanosomes. A descriptive study of these granulations at different examination times and in different lighting situations would allow us to obtain essential information for a better understanding of this area. Based on the results, larger studies could explore this area more finely in retinal pathologies involving dysfunctions of photoreceptors or of the pigmentary epithelium.

NCT ID: NCT03326830 Completed - Clinical trials for Acute Respiratory Failure With Hypoxia

Prehospital High-Flow Nasal Oxygen Therapy

PRHOXY-1
Start date: December 21, 2017
Phase: N/A
Study type: Interventional

The purpose of the present project is to compare High-Flow Nasal Oxygen therapy with Standard Oxygen therapy, initiated in the prehospital setting in patients with acute hypoxemia respiratory failure, in terms of oxygenation at arrival to the hospital and need of mechanical ventilation during the subsequent 28 days